Robert W. Duggan - May 19, 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
5/23/2022, 08:51 PM
Previous filing
Jul 2, 2021
Next filing
May 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +20K $0.00 20K May 19, 2022 Common Stock 20K $2.14 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +110K $0.00 110K May 19, 2022 Common Stock 110K $2.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022.
F2 The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022.